<PAGE>

                          SECURITIES AND EXCHANGE COMMISSION

                                   WASHINGTON, D.C.









                                  PHARMAGENICS, INC.



                          ----------------------------------


                                    Exhibit 10.60

                                          to

                            QUARTERLY REPORT ON FORM 10-Q

                         For Quarter Ended September 30, 1996



<PAGE>

                                                 CONFIDENTIAL

                                  May 1, 1996

Mr. George M. Gould
287 Tillou Road
South Orange, New Jersey 07079

Dear George:

On behalf of PharmaGenics, Inc., I am very pleased to offer you the position of
Senior Vice President, Corporate Affairs and Chief Counsel at PharmaGenics,
reporting to me.

    
Term of Offer:          This offer will expire on May 15, 1996.
      
Location:               4 Pearl Court, Allendale, New Jersey.

Start of Employment:    On or before May 20, 1996 you will begin employment,
                        spending, on average, at least 24 hours per week at
                        PharmaGenics or elsewhere on assignment as requested by
                        PharmaGenics ("part-time employment").  You will
                        convert to full-time employment at PharmaGenics at a
                        time that is mutually agreeable to you and to
                        PharmaGenics. 

Responsibilities:       You will be responsible for intellectual property
                        issues, oversee the disposition of all legal issues and
                        interact with the CEO, CFO and Director, Business
                        Development in the establishment and elaboration of
                        business development strategies and activites.

                        You represent and warrant that you are not, to the best
                        of your knowledge and belief, under any legal restraint
                        or restriction that would prevent or make unlawful your
                        accepting this employment offer or performing the
                        responsibilities herein and that you have disclosed to
                        PharmaGenics any and all constraints, confidentiality
                        commitments or employment restrictions that you have
                        with any other employer or business.   

<PAGE>

                                                 CONFIDENTIAL

Compensation:           Base salary of $8,751 per month while you are engaged
                        in part-time employment at PharmaGenics: base salary of
                        $14,585 per month upon conversion to full-time
                        employment.  Any annual or unscheduled bonuses are at
                        the discretion of the Company and based upon
                        performance and the Company's financial position.

Equity:                 Subject to approval by the Compensation Committee of
                        the Board of Directors, an option to purchase 50,000
                        shares of Common Stock, exercisable at fair market
                        value at the time of initiation of employment and 
                        vesting at a rate of twenty-five percent (25%) every
                        twelve months.  Sixty percent (60%) of the shares will
                        begin vesting on the date that you initiate part-time
                        employment at PharmaGenics; the remaining forty percent
                        of the shares will begin vesting on the date that you
                        begin full-time employment at PharmaGenics.

                        Upon termination for cause, the Company may purchase
                        all issued shares at cost and all remaining options
                        will expire.  "Cause" means (i) your willful misconduct
                        or gross negligence, or (ii) your breach of your
                        confidentiality agreement with the Company.  Issued
                        shares will be subject to a right of first refusal in
                        favor of the Company.  Options will be issued pursuant
                        to the Company's stock option plan and option
                        agreement.

Severance:              As an employee at will, you will be subject to
                        termination with or without cause.  Severance benefit
                        equal to three months salary will be payable (at the
                        rate in effect at the time of termination) in the event
                        your employment is terminated by the Company without
                        cause at any time following the date on which you begin
                        full-time employment.

Benefits:               Health (only if not covered by the Roche plan), 
                        disability, life insurance, 401(k) savings plan 
                        and vacation benefits as established by the Company 
                        for comparable positions.


<PAGE>

                                                 CONFIDENTIAL

Medical Testing:        This offer is contingent upon your satisfactorily
                        passing a urine test for drugs of abuse.

Contractual             You will be required to complete confidentiality and
Requirements:           patent assignment agreements upon commencement of
                        employment and to provide documentation confirming that
                        you are legally employable in the United States.

Please evidence your acceptance of the foregoing offer by signing and returning
one copy of this letter.

Yours truly,


/s/ Michael I. Sherman

Dr. Michael I. Sherman
President and Chief Executive Officer


Agreed and accepted this 2nd day of May, 1996.

/s/ George M. Gould
------------------------
George M. Gould